In this study, we found that BEZ235 induced upregulation of RTKs in breast cancer cells, including total protein of epidermal growth factor receptor (EGFR), HER2, HER3, insulin receptor, and insulin-like growth factor-1 (IGF-1) receptor, and their phosphorylation levels. This evidence concerns the gene ERBB3 and breast carcinoma.